Cubist Systematic Strategies, LLC Catalyst Biosciences, Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.2 - $0.35 $2,936 - $5,139	14,683 New	14,683 $5,000
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $112,257 - $145,935	-27,380 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.93 - $7.15 $134,983 - $195,767	27,380 New	27,380 $138,000
Q3 2018 Nov 14, 2018	SELL	$9.35 - $12.44 $65,590 - $87,266	-7,015 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$9.11 - $28.88 $63,906 - $202,593	7,015 New	7,015 $82,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.